Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The cell biology of CNS myelination.
Will the real multiple sclerosis please stand up?
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Dimethyl fumarate induces apoptosis of hematopoietic tumor cells via inhibition of NF-κB nuclear translocation and down-regulation of Bcl-xL and XIAP.
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Teriflunomide in multiple sclerosis: Added benefit not proven
Central fatigue in multiple sclerosis: a review of the literature.
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.
Dimethyl fumarate regulates histone deacetylase expression in astrocytes.
Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
Glial cells as drug targets: What does it take?
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
Multiple sclerosis in 2014: Progress in MS-classification, mechanisms and treatment.
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
How integrated are neurology and palliative care services? Results of a multicentre mapping exercise.
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.
Erratum to: Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
FGF-1 Triggers Pannexin-1 Hemichannel Opening in Spinal Astrocytes of Rodents and Promotes Inflammatory Responses in Acute Spinal Cord Slices.

Pages